However, genomic analyses in clear cell renal cell carcinoma (CCRCC) have revealed that female patients with elevated DKC1 expression also exhibit increased TERC levels, a pattern associated with reduced therapeutic response and shorter progression-free survival (Yuan et al., 2023). This evidence concerns the gene DKC1 and clear cell renal carcinoma.